Concepedia

Samuel Phen

SP

11

Publications

461

Citations

10

H-Index

2021

Active since

Affiliations

The University of Texas Southwestern Medical Center(Current)

Universität Hamburg

Johannes Gutenberg University Mainz

University Medical Center Hamburg-Eppendorf

Humanitas University

Samuel Phen is an author at The University of Texas Southwestern Medical Center specializing in medicine, oncology, and hepatology.

ORCID

Top concepts

Publications per year

2021–2024

11

Publications

11

Reproducible safety and efficacy of atezolizumab plus bevacizumab for HCC in clinical practice: Results of the AB-real study

Claudia Angela Maria Fulgenzi, Jaekyung Cheon, Antonio D’Alessio et al. · European Journal of Cancer · 2022 · 98 citations · Full text

, , +9

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios as Prognostic Biomarkers in Unresectable Hepatocellular Carcinoma Treated with Atezolizumab plus Bevacizumab

Linda Y. Wu, Claudia Angela Maria Fulgenzi, Antonio D’Alessio et al. · Cancers · 2022 · 68 citations · Full text

Efficacy and safety of immune checkpoint inhibitor rechallenge in individuals with hepatocellular carcinoma

Bernhard Scheiner, Daniel Roessler, Samuel Phen et al. · JHEP Reports · 2022 · 56 citations · Full text

, , +7

Characteristics and outcomes of immunotherapy-related liver injury in patients with hepatocellular carcinoma versus other advanced solid tumours

Ciro Celsa, Giuseppe Cabibbo, Claudia Angela Maria Fulgenzi et al. · Journal of Hepatology · 2023 · 56 citations · Full text

Cachexia is Prevalent in Patients With Hepatocellular Carcinoma and Associated With Worse Prognosis

Nicole E. Rich, Samuel Phen, Nirali Desai et al. · Clinical Gastroenterology and Hepatology · 2021 · 44 citations · Full text

, , +9

Rows per page

1–5 of 11